Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

被引：3
|
作者：
Loglisci, Giuseppina [1 ]
Breccia, Massimo [1 ]
Nanni, Mauro [1 ]
Mancini, Marco [1 ]
De Cuia, Rosa [1 ]
Cannella, Laura [1 ]
Salaroli, Adriano [1 ]
Federico, Vincenzo [1 ]
Serrao, Alessandra [1 ]
Loglisci, Maria Giovanna [1 ]
Santopietro, Michelina [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 07期
关键词：
BCR-ABL; GENE AMPLIFICATION; EXPRESSION; MESYLATE; THERAPY; ST1571; CELLS;
D O I：
10.3109/10428194.2011.565394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1372 / 1375
页数：4
相关论文
共 50 条
  • [1] Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance
    Cannella, Laura
    Breccia, Massimo
    Stefanizzi, Caterina
    Napoleone, Laura
    Santopietro, Michela
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 848 - 850
  • [2] Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    O'Brien, Susan
    Ravandi, Farhad
    Borthakur, Gautam
    Liu, David
    Bleickardt, Eric
    Chen, Tai-Tsang
    Kantarjian, Hagop M.
    CANCER, 2009, 115 (13) : 2912 - 2921
  • [3] Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
    Chen, Runzhe
    Wang, Fei
    Zhang, Xiaoping
    Gao, Chong
    Chen, Baoan
    OncoTargets and Therapy, 2015, 8 : 955 - 957
  • [4] Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    McCormack, Paul L.
    Keam, Susan J.
    BIODRUGS, 2012, 26 (01) : 61 - 64
  • [5] Overexpression of P-glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients
    Ammar, Mariam
    Louati, Nour
    Frikha, Imen
    Medhaffar, Moez
    Ghozzi, Hanen
    Elloumi, Moez
    Menif, Hela
    Zeghal, Khaled
    Ben Mahmoud, Lobna
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (09)
  • [6] A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
    Ma, Leyuan
    Shan, Yi
    Bai, Robert
    Xue, Liting
    Eide, Christopher A.
    Ou, Jianhong
    Zhu, Lihua J.
    Hutchinson, Lloyd
    Cerny, Jan
    Khoury, Hanna Jean
    Sheng, Zhi
    Druker, Brian J.
    Li, Shaoguang
    Green, Michael R.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (252)
  • [7] Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib
    Santos, Fabio P. S.
    Rodrigues, Morgani
    Bley Do Nascimento, Claudia Mac-Donald
    Kerbauy, Fabio R.
    Feitosa Ribeiro, Andreza Alice
    Kutner, Jose Mauro
    Hamerschlak, Nelson
    CYTOTHERAPY, 2010, 12 (01) : 113 - 115
  • [8] Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
    Apperley, Jane F.
    Cortes, Jorge E.
    Kim, Dong-Wook
    Roy, Lydia
    Roboz, Gail J.
    Rosti, Gianantonio
    Bullorsky, Eduardo O.
    Abruzzese, Elisabetta
    Hochhaus, Andreas
    Heim, Dominik
    de Souza, Carmino A.
    Larson, Richard A.
    Lipton, Jeffrey H.
    Khoury, H. Jean
    Kim, Hyeoung-Joon
    Sillaber, Christian
    Hughes, Timothy P.
    Erben, Philipp
    Van Tornout, Jan
    Stone, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3472 - 3479
  • [9] Imatinib Intolerance Is Associated With Blastic Phase Development in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    Luis Angeles-Velazquez, Jorge
    Hurtado-Monroy, Rafael
    Vargas-Viveros, Pablo
    Carrillo-Munoz, Silvia
    Candelaria-Hernandez, Myrna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S82 - S85
  • [10] Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Bruemmendorf, Tim H.
    Kim, Dong-Wook
    Turkina, Anna G.
    Shen, Zhi-Xiang
    Pasquini, Ricardo
    Khoury, H. Jean
    Arkin, Steven
    Volkert, Angela
    Besson, Nadine
    Abbas, Richat
    Wang, Junyuan
    Leip, Eric
    Gambacorti-Passerini, Carlo
    BLOOD, 2011, 118 (17) : 4567 - 4576
12345